Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Cash from Investing Activities (2023 - 2025)

Historic Cash from Investing Activities for Fractyl Health (GUTS) over the last 3 years, with Q3 2025 value amounting to -$8000.0.

  • Fractyl Health's Cash from Investing Activities rose 9624.41% to -$8000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$787000.0, marking a year-over-year increase of 5281.77%. This contributed to the annual value of -$1.8 million for FY2024, which is 39164.35% down from last year.
  • According to the latest figures from Q3 2025, Fractyl Health's Cash from Investing Activities is -$8000.0, which was up 9624.41% from -$98000.0 recorded in Q2 2025.
  • Fractyl Health's 5-year Cash from Investing Activities high stood at -$8000.0 for Q3 2025, and its period low was -$1.1 million during Q1 2024.
  • For the 3-year period, Fractyl Health's Cash from Investing Activities averaged around -$243454.5, with its median value being -$148000.0 (2023).
  • In the last 5 years, Fractyl Health's Cash from Investing Activities tumbled by 519500.0% in 2024 and then soared by 9624.41% in 2025.
  • Fractyl Health's Cash from Investing Activities (Quarter) stood at -$136000.0 in 2023, then plummeted by 71.32% to -$233000.0 in 2024, then surged by 96.57% to -$8000.0 in 2025.
  • Its Cash from Investing Activities stands at -$8000.0 for Q3 2025, versus -$98000.0 for Q2 2025 and -$448000.0 for Q1 2025.